13
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The Herbal Medicine Shoseiryu-to inhibits Allergen-induced Synthesis of Tumour Necrosis Factor Alpha by Peripheral Blood Mononuclear Cells in Patients with Perennial Allergic Rhinitis

Pages 118-125 | Published online: 08 Jul 2009
 

Abstract

The herbal medicine shoseiryu-to is an effective agent in the treatment of allergic rhinitis. However, the mechanism by which it exerts its action in improving patient symptoms remains unclear. It might affect the allergen-induced TH1 and/or TH2 responses. This study investigated whether the herbal medicine could affect cytokine synthesis by peripheral blood mononuclear cells (PBMCs) in response to the major Dermatophagoides farinae ( D. farinae ) allergen, Der f 1. PBMCs were obtained from 15 patients with perennial allergic rhinitis due to D. farinae , and were stimulated for 96 h with 10 &#119 g/ml Der f 1 in the presence or absence of 45 mg/ml shoseiryu-to. The culture supernatants were harvested to determine the synthesis of IgE, interleukin 5 (IL-5), IL-6, IL-10, interferon-gamma (IFN- &#110 ) and tumour necrosis factor alpha (TNF- &#102 ). The agent did not affect the allergen-induced synthesis of IL-5, IL-6 and IFN- &#110 , but somewhat decreased the synthesis of IgE and IL-10. This study highlighted an interesting pharmacological action of shoseiryu-to to substantially inhibit the allergen-induced synthesis of TNF- &#102 . Our study suggests that the shouseiryu-to may alleviate nasal symptoms in allergic rhinitis through control of the allergen-induced inflammatory process.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.